BackCERo Therapeutics Holdings - Warrants (13/02/2029) Overview

CERo Therapeutics Holdings - Warrants (13/02/2029) Accounts Payable

Track CERo Therapeutics Holdings - Warrants (13/02/2029)'s accounts payable ($7.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$7.69M
↑ 20.50% YoYΔ $1.31M vs prior year quarter

Peer average

Loading

CERo Therapeutics Holdings - Warrants (13/02/2029) Accounts Payable History

Loading

CERo Therapeutics Holdings - Warrants (13/02/2029) vs. peers: Accounts Payable Comparison

Loading

CERo Therapeutics Holdings - Warrants (13/02/2029) Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CERo Therapeutics Holdings - Warrants (13/02/2029) (CEROW) FAQ

As of the most recent data (March 2026), CEROW shows a accounts payable of $7.7M. That compares with $6.4M in the prior-year period — up 20.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CEROW's accounts payable is now $7.7M (was $6.4M) — a 20.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CERo Therapeutics Holdings - Warrants (13/02/2029) is outperforming or lagging.

Tracking CEROW's accounts payable over time shows whether CERo Therapeutics Holdings - Warrants (13/02/2029) is scaling, shrinking, or reshaping that part of the business. The current reading is $7.7M That compares with $6.4M in the prior-year period — up 20.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has CERo Therapeutics Holdings - Warrants (13/02/2029)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $7.7M) with ownership activity and broader fundamentals.